209 related articles for article (PubMed ID: 4618388)
1. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
2. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Abendroth D; Sunder-Plassmann L
Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
[No Abstract] [Full Text] [Related]
3. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
[No Abstract] [Full Text] [Related]
4. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
Ratschow R
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407
[TBL] [Abstract][Full Text] [Related]
5. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Horsch S
Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
[No Abstract] [Full Text] [Related]
6. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
Ranft J; Heidrich H; Lammersen T
J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
[TBL] [Abstract][Full Text] [Related]
7. [Naftidrofuryl in the treatment of obstructive arterial diseases of the lower extremities].
Ciammaichella A; Solitro A; Arcuri P
Minerva Cardioangiol; 1975 Oct; 23(10):607-21. PubMed ID: 1232566
[No Abstract] [Full Text] [Related]
8. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
Heidrich VH; Baethke R; Beyer KH
Arzneimittelforschung; 1975 Mar; 25(3):429-31. PubMed ID: 1174049
[TBL] [Abstract][Full Text] [Related]
9. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
[TBL] [Abstract][Full Text] [Related]
10. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
Pointel JP; Thomas C; Mosnier M; Percebois G; Debry G
Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072
[TBL] [Abstract][Full Text] [Related]
11. [Changes of lower leg blood circulation during oral therapy with naftidrofuryl (dusodril)].
Kriessmann A; Rädler M
Munch Med Wochenschr; 1973 Mar; 115(12):508-10. PubMed ID: 4739661
[No Abstract] [Full Text] [Related]
12. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
13. [Effects of naftidrofuryl through prolonged intra-arterial perfusion in obliterating arteriopathies of the lower limbs].
Cospite M; Ferrara F; Ballo M; Lo Presti T; Raimondi F; Meli F; Milio G
Minerva Cardioangiol; 1980 May; 28(5):359-66. PubMed ID: 7207826
[No Abstract] [Full Text] [Related]
14. [Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
Heidrich H; Ranft J
Vasa Suppl; 1988; 24():17-20. PubMed ID: 3212599
[No Abstract] [Full Text] [Related]
15. [Naftidrofuryl in cerebrovascular sclerosis. Ophthalmodynamic findings in acute and long term experiment].
Finke J; Kettlitz UP
ZFA (Stuttgart); 1976 Sep; 52(27):1400-3. PubMed ID: 790807
[No Abstract] [Full Text] [Related]
16. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
Krupiński K; Bielawiec M; Szpak A; Płonowski A
Mater Med Pol; 1994; 26(1):17-20. PubMed ID: 7857406
[TBL] [Abstract][Full Text] [Related]
17. [Thrombocyte function in parenteral naftidrofuryl therapy].
Janka HU; Rinninger F; Mehnert H
Ther Ggw; 1982 Jul; 121(7):422-33. PubMed ID: 7051401
[No Abstract] [Full Text] [Related]
18. [Effect of a transient intravenous infusion of isozsuprin on the peripheral blood flow in patients suffering from arterial occlusive disease of the limbs. A contribution to the effect of systemically-administered vasoactive drugs].
Ehringer H; Scheiber V
Wien Klin Wochenschr; 1972 Dec; 24(50):801-8. PubMed ID: 4642105
[No Abstract] [Full Text] [Related]
19. Naftidrofuryl in the treatment of recent stroke. Results of a controlled clinical trial.
Steiner TJ
Vasa Suppl; 1988; 24():44-7. PubMed ID: 3062824
[No Abstract] [Full Text] [Related]
20. [Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl].
Rey JL; Quiret JC; Gamain J; Errasti M
Nouv Presse Med; 1978 May; 7(21):1864. PubMed ID: 673747
[No Abstract] [Full Text] [Related]
[Next] [New Search]